passages: 1180
passages: document
passages: [ Intravenous treatment of postpartum anemia with trivalent ferrum preparation ] . AIM OF THE STUDY To assess the effectivity and safeness of intravenous treatment of pospartal anemia with trivalent ferrum preparation . TYPE OF THE STUDY Prospective randomized study . SETTING Department of Obstetric and Gynecology 2nd Medical Faculty Charles University and Teaching Hospital Motol , Prague , and Department of Obstetric and Gynecology 1st Medical Faculty and Teaching Hospital Bulovka , Prague . METHODS 500 mg of sacharose ferric oxide ( Venofer ) was intravenously administered in two days regimen to 50 women with clinical and lab signs of postpartal anemia . The effect of administered drug was determined by comparsion of values of red blood count recovered before the treatment , 2nd or 3rd day post administration and two weeks later . The serum values of soluble transferrin receptors and ferritin were observed as markers of iron cell saturation and body iron reserves , too . Integral part of the study was the monitoring of adverse events during the treatment . RESULTS Venofer came in sight as effective drug in the treatment of pospartal anemia and could become as the alternative to blood transfusion in mid-severe cases . It should be emphasized that we have not encountered any serious adverse event with intravenous trivalent saccharose ferric oxide treatment .
entities: 1181
entities: Intervention_Pharmacological
entities: trivalent ferrum preparation ]
entities: 1182
entities: Intervention_Pharmacological
entities: trivalent ferrum preparation .
entities: 1183
entities: Intervention_Pharmacological
entities: sacharose ferric oxide ( Venofer )
entities: 1184
entities: Intervention_Pharmacological
entities: Venofer
entities: 1185
entities: Intervention_Pharmacological
entities: trivalent saccharose ferric oxide
entities: 1186
entities: Outcome_Other
entities: effectivity
entities: 1187
entities: Outcome_Other
entities: safeness
entities: 1188
entities: Outcome_Physical
entities: values of red blood count
entities: 1189
entities: Outcome_Physical
entities: serum values of soluble transferrin receptors and ferritin
entities: 1190
entities: Outcome_Physical
entities: iron cell saturation
entities: 1191
entities: Outcome_Physical
entities: body iron reserves
entities: 1192
entities: Outcome_Adverse-effects
entities: adverse events
entities: 1193
entities: Outcome_Other
entities: effective
entities: 1194
entities: Outcome_Adverse-effects
entities: serious adverse event
entities: 1195
entities: Participant_Condition
entities: postpartum
entities: 1196
entities: Participant_Condition
entities: Prague
entities: 1197
entities: Participant_Condition
entities: Prague
entities: 1198
entities: Participant_Sample-size
entities: 50
entities: 1199
entities: Participant_Sex
entities: women
entities: 1200
entities: Participant_Condition
entities: clinical and lab signs of postpartal anemia